Global At-Home Drug of Abuse (DOA) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global At-Home Drug of Abuse (DOA) Testing market size was valued at USD 425.2 million in 2023 and is forecast to a readjusted size of USD 836.2 million by 2030 with a CAGR of 10.1% during review period.
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
The Global Info Research report includes an overview of the development of the At-Home Drug of Abuse (DOA) Testing industry chain, the market status of Urine (Test Cups, Test Dip Cards), Saliva (Test Cups, Test Dip Cards), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of At-Home Drug of Abuse (DOA) Testing.
Regionally, the report analyzes the At-Home Drug of Abuse (DOA) Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global At-Home Drug of Abuse (DOA) Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the At-Home Drug of Abuse (DOA) Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the At-Home Drug of Abuse (DOA) Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Test Cups, Test Dip Cards).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the At-Home Drug of Abuse (DOA) Testing market.
Regional Analysis: The report involves examining the At-Home Drug of Abuse (DOA) Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the At-Home Drug of Abuse (DOA) Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to At-Home Drug of Abuse (DOA) Testing:
Company Analysis: Report covers individual At-Home Drug of Abuse (DOA) Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards At-Home Drug of Abuse (DOA) Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Urine, Saliva).
Technology Analysis: Report covers specific technologies relevant to At-Home Drug of Abuse (DOA) Testing. It assesses the current state, advancements, and potential future developments in At-Home Drug of Abuse (DOA) Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the At-Home Drug of Abuse (DOA) Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
At-Home Drug of Abuse (DOA) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe At-Home Drug of Abuse (DOA) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of At-Home Drug of Abuse (DOA) Testing, with revenue, gross margin and global market share of At-Home Drug of Abuse (DOA) Testing from 2019 to 2024.
Chapter 3, the At-Home Drug of Abuse (DOA) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and At-Home Drug of Abuse (DOA) Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of At-Home Drug of Abuse (DOA) Testing.
Chapter 13, to describe At-Home Drug of Abuse (DOA) Testing research findings and conclusion.
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
The Global Info Research report includes an overview of the development of the At-Home Drug of Abuse (DOA) Testing industry chain, the market status of Urine (Test Cups, Test Dip Cards), Saliva (Test Cups, Test Dip Cards), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of At-Home Drug of Abuse (DOA) Testing.
Regionally, the report analyzes the At-Home Drug of Abuse (DOA) Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global At-Home Drug of Abuse (DOA) Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the At-Home Drug of Abuse (DOA) Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the At-Home Drug of Abuse (DOA) Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Test Cups, Test Dip Cards).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the At-Home Drug of Abuse (DOA) Testing market.
Regional Analysis: The report involves examining the At-Home Drug of Abuse (DOA) Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the At-Home Drug of Abuse (DOA) Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to At-Home Drug of Abuse (DOA) Testing:
Company Analysis: Report covers individual At-Home Drug of Abuse (DOA) Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards At-Home Drug of Abuse (DOA) Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Urine, Saliva).
Technology Analysis: Report covers specific technologies relevant to At-Home Drug of Abuse (DOA) Testing. It assesses the current state, advancements, and potential future developments in At-Home Drug of Abuse (DOA) Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the At-Home Drug of Abuse (DOA) Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
At-Home Drug of Abuse (DOA) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Test Cups
- Test Dip Cards
- Test Strips
- Others
- Urine
- Saliva
- Hair
- Others
- UCP Biosciences
- Orient New Life Medical
- Express Diagnostics Int’l
- Assure Tech (Hangzhou)
- Psychemedics Corporation
- Confirm BioSciences
- Phamatech
- Home Health (U.K.) Ltd.
- Quest Products
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe At-Home Drug of Abuse (DOA) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of At-Home Drug of Abuse (DOA) Testing, with revenue, gross margin and global market share of At-Home Drug of Abuse (DOA) Testing from 2019 to 2024.
Chapter 3, the At-Home Drug of Abuse (DOA) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and At-Home Drug of Abuse (DOA) Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of At-Home Drug of Abuse (DOA) Testing.
Chapter 13, to describe At-Home Drug of Abuse (DOA) Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of At-Home Drug of Abuse (DOA) Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of At-Home Drug of Abuse (DOA) Testing by Type
1.3.1 Overview: Global At-Home Drug of Abuse (DOA) Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type in 2023
1.3.3 Test Cups
1.3.4 Test Dip Cards
1.3.5 Test Strips
1.3.6 Others
1.4 Global At-Home Drug of Abuse (DOA) Testing Market by Application
1.4.1 Overview: Global At-Home Drug of Abuse (DOA) Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Urine
1.4.3 Saliva
1.4.4 Hair
1.4.5 Others
1.5 Global At-Home Drug of Abuse (DOA) Testing Market Size & Forecast
1.6 Global At-Home Drug of Abuse (DOA) Testing Market Size and Forecast by Region
1.6.1 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region, (2019-2030)
1.6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.6 South America At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 UCP Biosciences
2.1.1 UCP Biosciences Details
2.1.2 UCP Biosciences Major Business
2.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.1.4 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 UCP Biosciences Recent Developments and Future Plans
2.2 Orient New Life Medical
2.2.1 Orient New Life Medical Details
2.2.2 Orient New Life Medical Major Business
2.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.2.4 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Orient New Life Medical Recent Developments and Future Plans
2.3 Express Diagnostics Int’l
2.3.1 Express Diagnostics Int’l Details
2.3.2 Express Diagnostics Int’l Major Business
2.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.3.4 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Express Diagnostics Int’l Recent Developments and Future Plans
2.4 Assure Tech (Hangzhou)
2.4.1 Assure Tech (Hangzhou) Details
2.4.2 Assure Tech (Hangzhou) Major Business
2.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.4.4 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Assure Tech (Hangzhou) Recent Developments and Future Plans
2.5 Psychemedics Corporation
2.5.1 Psychemedics Corporation Details
2.5.2 Psychemedics Corporation Major Business
2.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.5.4 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Psychemedics Corporation Recent Developments and Future Plans
2.6 Confirm BioSciences
2.6.1 Confirm BioSciences Details
2.6.2 Confirm BioSciences Major Business
2.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.6.4 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Confirm BioSciences Recent Developments and Future Plans
2.7 Phamatech
2.7.1 Phamatech Details
2.7.2 Phamatech Major Business
2.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.7.4 Phamatech At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Phamatech Recent Developments and Future Plans
2.8 Home Health (U.K.) Ltd.
2.8.1 Home Health (U.K.) Ltd. Details
2.8.2 Home Health (U.K.) Ltd. Major Business
2.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.8.4 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Home Health (U.K.) Ltd. Recent Developments and Future Plans
2.9 Quest Products
2.9.1 Quest Products Details
2.9.2 Quest Products Major Business
2.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.9.4 Quest Products At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Quest Products Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global At-Home Drug of Abuse (DOA) Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of At-Home Drug of Abuse (DOA) Testing by Company Revenue
3.2.2 Top 3 At-Home Drug of Abuse (DOA) Testing Players Market Share in 2023
3.2.3 Top 6 At-Home Drug of Abuse (DOA) Testing Players Market Share in 2023
3.3 At-Home Drug of Abuse (DOA) Testing Market: Overall Company Footprint Analysis
3.3.1 At-Home Drug of Abuse (DOA) Testing Market: Region Footprint
3.3.2 At-Home Drug of Abuse (DOA) Testing Market: Company Product Type Footprint
3.3.3 At-Home Drug of Abuse (DOA) Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global At-Home Drug of Abuse (DOA) Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global At-Home Drug of Abuse (DOA) Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
6.2 North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country
6.3.1 North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
6.3.2 United States At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
6.3.3 Canada At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country
7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
7.3.2 Germany At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.3 France At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.5 Russia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.6 Italy At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region
8.3.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2019-2030)
8.3.2 China At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.3 Japan At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.5 India At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.7 Australia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
9.2 South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
9.3 South America At-Home Drug of Abuse (DOA) Testing Market Size by Country
9.3.1 South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country
10.3.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
10.3.4 UAE At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 At-Home Drug of Abuse (DOA) Testing Market Drivers
11.2 At-Home Drug of Abuse (DOA) Testing Market Restraints
11.3 At-Home Drug of Abuse (DOA) Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 At-Home Drug of Abuse (DOA) Testing Industry Chain
12.2 At-Home Drug of Abuse (DOA) Testing Upstream Analysis
12.3 At-Home Drug of Abuse (DOA) Testing Midstream Analysis
12.4 At-Home Drug of Abuse (DOA) Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of At-Home Drug of Abuse (DOA) Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of At-Home Drug of Abuse (DOA) Testing by Type
1.3.1 Overview: Global At-Home Drug of Abuse (DOA) Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type in 2023
1.3.3 Test Cups
1.3.4 Test Dip Cards
1.3.5 Test Strips
1.3.6 Others
1.4 Global At-Home Drug of Abuse (DOA) Testing Market by Application
1.4.1 Overview: Global At-Home Drug of Abuse (DOA) Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Urine
1.4.3 Saliva
1.4.4 Hair
1.4.5 Others
1.5 Global At-Home Drug of Abuse (DOA) Testing Market Size & Forecast
1.6 Global At-Home Drug of Abuse (DOA) Testing Market Size and Forecast by Region
1.6.1 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region, (2019-2030)
1.6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.6 South America At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 UCP Biosciences
2.1.1 UCP Biosciences Details
2.1.2 UCP Biosciences Major Business
2.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.1.4 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 UCP Biosciences Recent Developments and Future Plans
2.2 Orient New Life Medical
2.2.1 Orient New Life Medical Details
2.2.2 Orient New Life Medical Major Business
2.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.2.4 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Orient New Life Medical Recent Developments and Future Plans
2.3 Express Diagnostics Int’l
2.3.1 Express Diagnostics Int’l Details
2.3.2 Express Diagnostics Int’l Major Business
2.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.3.4 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Express Diagnostics Int’l Recent Developments and Future Plans
2.4 Assure Tech (Hangzhou)
2.4.1 Assure Tech (Hangzhou) Details
2.4.2 Assure Tech (Hangzhou) Major Business
2.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.4.4 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Assure Tech (Hangzhou) Recent Developments and Future Plans
2.5 Psychemedics Corporation
2.5.1 Psychemedics Corporation Details
2.5.2 Psychemedics Corporation Major Business
2.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.5.4 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Psychemedics Corporation Recent Developments and Future Plans
2.6 Confirm BioSciences
2.6.1 Confirm BioSciences Details
2.6.2 Confirm BioSciences Major Business
2.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.6.4 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Confirm BioSciences Recent Developments and Future Plans
2.7 Phamatech
2.7.1 Phamatech Details
2.7.2 Phamatech Major Business
2.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.7.4 Phamatech At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Phamatech Recent Developments and Future Plans
2.8 Home Health (U.K.) Ltd.
2.8.1 Home Health (U.K.) Ltd. Details
2.8.2 Home Health (U.K.) Ltd. Major Business
2.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.8.4 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Home Health (U.K.) Ltd. Recent Developments and Future Plans
2.9 Quest Products
2.9.1 Quest Products Details
2.9.2 Quest Products Major Business
2.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.9.4 Quest Products At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Quest Products Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global At-Home Drug of Abuse (DOA) Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of At-Home Drug of Abuse (DOA) Testing by Company Revenue
3.2.2 Top 3 At-Home Drug of Abuse (DOA) Testing Players Market Share in 2023
3.2.3 Top 6 At-Home Drug of Abuse (DOA) Testing Players Market Share in 2023
3.3 At-Home Drug of Abuse (DOA) Testing Market: Overall Company Footprint Analysis
3.3.1 At-Home Drug of Abuse (DOA) Testing Market: Region Footprint
3.3.2 At-Home Drug of Abuse (DOA) Testing Market: Company Product Type Footprint
3.3.3 At-Home Drug of Abuse (DOA) Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global At-Home Drug of Abuse (DOA) Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global At-Home Drug of Abuse (DOA) Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
6.2 North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country
6.3.1 North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
6.3.2 United States At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
6.3.3 Canada At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country
7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
7.3.2 Germany At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.3 France At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.5 Russia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.6 Italy At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region
8.3.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2019-2030)
8.3.2 China At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.3 Japan At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.5 India At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.7 Australia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
9.2 South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
9.3 South America At-Home Drug of Abuse (DOA) Testing Market Size by Country
9.3.1 South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country
10.3.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
10.3.4 UAE At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 At-Home Drug of Abuse (DOA) Testing Market Drivers
11.2 At-Home Drug of Abuse (DOA) Testing Market Restraints
11.3 At-Home Drug of Abuse (DOA) Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 At-Home Drug of Abuse (DOA) Testing Industry Chain
12.2 At-Home Drug of Abuse (DOA) Testing Upstream Analysis
12.3 At-Home Drug of Abuse (DOA) Testing Midstream Analysis
12.4 At-Home Drug of Abuse (DOA) Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. UCP Biosciences Company Information, Head Office, and Major Competitors
Table 6. UCP Biosciences Major Business
Table 7. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 8. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. UCP Biosciences Recent Developments and Future Plans
Table 10. Orient New Life Medical Company Information, Head Office, and Major Competitors
Table 11. Orient New Life Medical Major Business
Table 12. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 13. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Orient New Life Medical Recent Developments and Future Plans
Table 15. Express Diagnostics Int’l Company Information, Head Office, and Major Competitors
Table 16. Express Diagnostics Int’l Major Business
Table 17. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 18. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Express Diagnostics Int’l Recent Developments and Future Plans
Table 20. Assure Tech (Hangzhou) Company Information, Head Office, and Major Competitors
Table 21. Assure Tech (Hangzhou) Major Business
Table 22. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 23. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Assure Tech (Hangzhou) Recent Developments and Future Plans
Table 25. Psychemedics Corporation Company Information, Head Office, and Major Competitors
Table 26. Psychemedics Corporation Major Business
Table 27. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 28. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Psychemedics Corporation Recent Developments and Future Plans
Table 30. Confirm BioSciences Company Information, Head Office, and Major Competitors
Table 31. Confirm BioSciences Major Business
Table 32. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 33. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Confirm BioSciences Recent Developments and Future Plans
Table 35. Phamatech Company Information, Head Office, and Major Competitors
Table 36. Phamatech Major Business
Table 37. Phamatech At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 38. Phamatech At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Phamatech Recent Developments and Future Plans
Table 40. Home Health (U.K.) Ltd. Company Information, Head Office, and Major Competitors
Table 41. Home Health (U.K.) Ltd. Major Business
Table 42. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 43. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Home Health (U.K.) Ltd. Recent Developments and Future Plans
Table 45. Quest Products Company Information, Head Office, and Major Competitors
Table 46. Quest Products Major Business
Table 47. Quest Products At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 48. Quest Products At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Quest Products Recent Developments and Future Plans
Table 50. Global At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) by Players (2019-2024)
Table 51. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Players (2019-2024)
Table 52. Breakdown of At-Home Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in At-Home Drug of Abuse (DOA) Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key At-Home Drug of Abuse (DOA) Testing Players
Table 55. At-Home Drug of Abuse (DOA) Testing Market: Company Product Type Footprint
Table 56. At-Home Drug of Abuse (DOA) Testing Market: Company Product Application Footprint
Table 57. At-Home Drug of Abuse (DOA) Testing New Market Entrants and Barriers to Market Entry
Table 58. At-Home Drug of Abuse (DOA) Testing Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global At-Home Drug of Abuse (DOA) Testing Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Share by Type (2019-2024)
Table 61. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Forecast by Type (2025-2030)
Table 62. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024)
Table 63. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Forecast by Application (2025-2030)
Table 64. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 94. At-Home Drug of Abuse (DOA) Testing Raw Material
Table 95. Key Suppliers of At-Home Drug of Abuse (DOA) Testing Raw Materials
Table 1. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. UCP Biosciences Company Information, Head Office, and Major Competitors
Table 6. UCP Biosciences Major Business
Table 7. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 8. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. UCP Biosciences Recent Developments and Future Plans
Table 10. Orient New Life Medical Company Information, Head Office, and Major Competitors
Table 11. Orient New Life Medical Major Business
Table 12. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 13. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Orient New Life Medical Recent Developments and Future Plans
Table 15. Express Diagnostics Int’l Company Information, Head Office, and Major Competitors
Table 16. Express Diagnostics Int’l Major Business
Table 17. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 18. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Express Diagnostics Int’l Recent Developments and Future Plans
Table 20. Assure Tech (Hangzhou) Company Information, Head Office, and Major Competitors
Table 21. Assure Tech (Hangzhou) Major Business
Table 22. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 23. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Assure Tech (Hangzhou) Recent Developments and Future Plans
Table 25. Psychemedics Corporation Company Information, Head Office, and Major Competitors
Table 26. Psychemedics Corporation Major Business
Table 27. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 28. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Psychemedics Corporation Recent Developments and Future Plans
Table 30. Confirm BioSciences Company Information, Head Office, and Major Competitors
Table 31. Confirm BioSciences Major Business
Table 32. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 33. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Confirm BioSciences Recent Developments and Future Plans
Table 35. Phamatech Company Information, Head Office, and Major Competitors
Table 36. Phamatech Major Business
Table 37. Phamatech At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 38. Phamatech At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Phamatech Recent Developments and Future Plans
Table 40. Home Health (U.K.) Ltd. Company Information, Head Office, and Major Competitors
Table 41. Home Health (U.K.) Ltd. Major Business
Table 42. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 43. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Home Health (U.K.) Ltd. Recent Developments and Future Plans
Table 45. Quest Products Company Information, Head Office, and Major Competitors
Table 46. Quest Products Major Business
Table 47. Quest Products At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 48. Quest Products At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Quest Products Recent Developments and Future Plans
Table 50. Global At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) by Players (2019-2024)
Table 51. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Players (2019-2024)
Table 52. Breakdown of At-Home Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in At-Home Drug of Abuse (DOA) Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key At-Home Drug of Abuse (DOA) Testing Players
Table 55. At-Home Drug of Abuse (DOA) Testing Market: Company Product Type Footprint
Table 56. At-Home Drug of Abuse (DOA) Testing Market: Company Product Application Footprint
Table 57. At-Home Drug of Abuse (DOA) Testing New Market Entrants and Barriers to Market Entry
Table 58. At-Home Drug of Abuse (DOA) Testing Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global At-Home Drug of Abuse (DOA) Testing Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Share by Type (2019-2024)
Table 61. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Forecast by Type (2025-2030)
Table 62. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024)
Table 63. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Forecast by Application (2025-2030)
Table 64. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 94. At-Home Drug of Abuse (DOA) Testing Raw Material
Table 95. Key Suppliers of At-Home Drug of Abuse (DOA) Testing Raw Materials
LIST OF FIGURES
Figure 1. At-Home Drug of Abuse (DOA) Testing Picture
Figure 2. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type in 2023
Figure 4. Test Cups
Figure 5. Test Dip Cards
Figure 6. Test Strips
Figure 7. Others
Figure 8. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application in 2023
Figure 10. Urine Picture
Figure 11. Saliva Picture
Figure 12. Hair Picture
Figure 13. Others Picture
Figure 14. Global At-Home Drug of Abuse (DOA) Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global At-Home Drug of Abuse (DOA) Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market At-Home Drug of Abuse (DOA) Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Region (2019-2030)
Figure 18. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Region in 2023
Figure 19. North America At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. South America At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 24. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Players in 2023
Figure 25. At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players At-Home Drug of Abuse (DOA) Testing Market Share in 2023
Figure 27. Global Top 6 Players At-Home Drug of Abuse (DOA) Testing Market Share in 2023
Figure 28. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Share by Type (2019-2024)
Figure 29. Global At-Home Drug of Abuse (DOA) Testing Market Share Forecast by Type (2025-2030)
Figure 30. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Share by Application (2019-2024)
Figure 31. Global At-Home Drug of Abuse (DOA) Testing Market Share Forecast by Application (2025-2030)
Figure 32. North America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 33. North America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 34. North America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Country (2019-2030)
Figure 35. United States At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. France At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Region (2019-2030)
Figure 49. China At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. India At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 55. South America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 56. South America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 57. South America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. At-Home Drug of Abuse (DOA) Testing Market Drivers
Figure 67. At-Home Drug of Abuse (DOA) Testing Market Restraints
Figure 68. At-Home Drug of Abuse (DOA) Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of At-Home Drug of Abuse (DOA) Testing in 2023
Figure 71. Manufacturing Process Analysis of At-Home Drug of Abuse (DOA) Testing
Figure 72. At-Home Drug of Abuse (DOA) Testing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. At-Home Drug of Abuse (DOA) Testing Picture
Figure 2. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type in 2023
Figure 4. Test Cups
Figure 5. Test Dip Cards
Figure 6. Test Strips
Figure 7. Others
Figure 8. Global At-Home Drug of Abuse (DOA) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application in 2023
Figure 10. Urine Picture
Figure 11. Saliva Picture
Figure 12. Hair Picture
Figure 13. Others Picture
Figure 14. Global At-Home Drug of Abuse (DOA) Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global At-Home Drug of Abuse (DOA) Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market At-Home Drug of Abuse (DOA) Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Region (2019-2030)
Figure 18. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Region in 2023
Figure 19. North America At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. South America At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 24. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Players in 2023
Figure 25. At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players At-Home Drug of Abuse (DOA) Testing Market Share in 2023
Figure 27. Global Top 6 Players At-Home Drug of Abuse (DOA) Testing Market Share in 2023
Figure 28. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Share by Type (2019-2024)
Figure 29. Global At-Home Drug of Abuse (DOA) Testing Market Share Forecast by Type (2025-2030)
Figure 30. Global At-Home Drug of Abuse (DOA) Testing Consumption Value Share by Application (2019-2024)
Figure 31. Global At-Home Drug of Abuse (DOA) Testing Market Share Forecast by Application (2025-2030)
Figure 32. North America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 33. North America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 34. North America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Country (2019-2030)
Figure 35. United States At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. France At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Region (2019-2030)
Figure 49. China At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. India At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 55. South America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 56. South America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 57. South America At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE At-Home Drug of Abuse (DOA) Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. At-Home Drug of Abuse (DOA) Testing Market Drivers
Figure 67. At-Home Drug of Abuse (DOA) Testing Market Restraints
Figure 68. At-Home Drug of Abuse (DOA) Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of At-Home Drug of Abuse (DOA) Testing in 2023
Figure 71. Manufacturing Process Analysis of At-Home Drug of Abuse (DOA) Testing
Figure 72. At-Home Drug of Abuse (DOA) Testing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
